Your search returned 5 results.

Results
	1.	Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy. [electronic resource] by Cogle, Christopher R Ortendahl, Jesse D Bentley, Tanya Gk Anene, Ayanna M Megaffin, Scott McKearn, Thomas J Petrone, Michael E Mukherjee, Sudipto Producer: 20161213 In: Expert review of pharmacoeconomics & outcomes research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study. [electronic resource] by Ricart, Alejandro D Sarantopoulos, John Calvo, Emiliano Chu, Quincy S Greene, Douglas Nathan, Faith E Petrone, Michael E Tolcher, Anthony W Papadopoulos, Kyriakos P Producer: 20090707 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail. [electronic resource] by Cogle, Christopher R Kurtin, Sandra E Bentley, Tanya G K Broder, Michael S Chang, Eunice Megaffin, Scott Fruchtman, Steven Petrone, Michael E Mukherjee, Sudipto Producer: 20180214 In: The oncologist vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia. [electronic resource] by Navada, Shyamala C Fruchtman, Steven M Odchimar-Reissig, Rosalie Demakos, Erin P Petrone, Michael E Zbyszewski, Patrick S Holland, James F Silverman, Lewis R Producer: 20181105 In: Leukemia research vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. [electronic resource] by Sternberg, Cora N Petrylak, Daniel P Sartor, Oliver Witjes, J Alfred Demkow, Tomasz Ferrero, Jean-Marc Eymard, Jean-Christophe Falcon, Silvia Calabrò, Fabio James, Nicholas Bodrogi, Istvan Harper, Peter Wirth, Manfred Berry, William Petrone, Michael E McKearn, Thomas J Noursalehi, Mojtaba George, Martine Rozencweig, Marcel Producer: 20100106 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)